Advertisement
Screener

OCUGEN, INC. (OCGN) Patents: Active

OCUGEN, INC. Active Patents

15 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2021-01-22: Application 17156062; Invention CELL-SUPPORT MATRIX HAVING NARROWLY DEFINED UNIFORMLY VERTICALLY AND NON-RANDOMLY ORGANIZED POROSITY AND PORE DENSITY AND A METHOD FOR PREPARATION THEREOF; Applicant Ocugen, Inc.; Status Patented Case.
  • 2020-11-16: Application 17098851; Invention METHOD FOR USE OF A DOUBLE-STRUCTURED TISSUE IMPLANT FOR TREATMENT OF TISSUE DEFECTS; Applicant Ocugen, Inc.; Status Patented Case.
  • 2019-12-06: Application 16706372; Invention CELL-SUPPORT MATRIX HAVING NARROWLY DEFINED UNIFORMLY VERTICALLY AND NON-RANDOMLY ORGANIZED POROSITY AND PORE DENSITY AND A METHOD FOR PREPARATION THEREOF; Applicant HISTOGENICS CORPORATION; Status Patented Case.
  • 2018-09-14: Application 16131234; Invention CELL AND TISSUE CULTURE CONTAINER; Applicant Histogenics Corporation; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2021-01-2217156062CELL-SUPPORT MATRIX HAVING NARROWLY DEFINED UNIFORMLY VERTICALLY AND NON-RANDOMLY ORGANIZED POROSITY AND PORE DENSITY AND A METHOD FOR PREPARATION THEREOFOcugen, Inc.Patented Case2025-07-0112344860US20210246418A1
Robert Lane Smith
Laurence J.B. Tarrant
Akihiko Kusanagi
Hans P.I. Claesson
United States
United States
United States
United States
KOSAR, AARON J
2020-11-1617098851METHOD FOR USE OF A DOUBLE-STRUCTURED TISSUE IMPLANT FOR TREATMENT OF TISSUE DEFECTSOcugen, Inc.Patented Case2023-05-1611648102US20210059805A1
Sonya Shortkroff
Laurence J.B. Tarrant
Eric J. Roos
Robert Lane Smith
Hans P.I. Claesson
United States
United States
United States
United States
United States
SCHERBEL, TODD J
2019-12-0616706372CELL-SUPPORT MATRIX HAVING NARROWLY DEFINED UNIFORMLY VERTICALLY AND NON-RANDOMLY ORGANIZED POROSITY AND PORE DENSITY AND A METHOD FOR PREPARATION THEREOFHISTOGENICS CORPORATIONPatented Case2021-01-2610900017US20200224155A1
Robert Lane Smith
Laurence J.B. Tarrant
Akihiko Kusanagi
Hans P.I. Claesson
United States
United States
United States
United States
KOSAR, AARON J
2018-09-1416131234CELL AND TISSUE CULTURE CONTAINERHistogenics CorporationPatented Case2023-01-1711555172US20190010439A1
Eric Blahut
United States
BOWERS, NATHAN ANDREW
2018-05-1115977552METHOD FOR USE OF A DOUBLE-STRUCTURED TISSUE IMPLANT FOR TREATMENT OF TISSUE DEFECTSHistogenics CorporationPatented Case2020-11-2410842610US20180256309A1
Sonya Shortkroff
Laurence J.B. Tarrant
Eric J. Roos
Robert Lane Smith
Hans P.I. Claesson
United States
United States
United States
United States
United States
SCHERBEL, TODD J
2018-04-0515946709OPHTHALMIC COMPOSITIONS AND METHODS OF USEOcugen, Inc.Patented Case2020-02-1110555947US20180333414A1
Shankar Musunuri
Sandeep Jain
Rasappa Arumugham
Arun K. Upadhyay
Matthew Nudell
Gopalam Somasekhar
United States
United States
United States
United States
United States
United States
HEYER, DENNIS
2018-01-3015883361PRESERVATIVE FREE OCULAR COMPOSITIONS AND METHODS FOR USING THE SAME FOR TREATING DRY EYE DISEASE AND OTHER EYE DISORDERSOcugen, Inc.
The Board of Trustees of the University of Illinois
Patented Case2020-08-2510751337US20180153885A1
Sandeep Jain
Uday Bhaskar Kompella
Shankar Musunuri
United States
United States
United States
FAY, ZOHREH ALEMZADEH
2017-03-2015464290METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISORDERSOcugen, Inc.
The Board of Trustees of the University of Illinois
Patented Case2018-01-309877964US20170189396A1
Sandeep Jain
Uday Bhaskar Kompella
Shankar Musunuri
United States
United States
United States
TRUONG, QUANGLONG N
2016-06-2115188579DOUBLE-STRUCTURED TISSUE IMPLANT AND A METHOD FOR PREPARATION AND USE THEREOFHistogenics CorporationPatented Case2017-06-279687590US20160317713A1
Hans Peter Ingemar Claesson
Laurence J.B. Tarrant
Robert Lane Smith
Sonya Shortkroff
United States
United States
United States
United States
RUSSEL, JEFFREY E
2016-02-2315051654Methods and Compositions for Treating Dry Eye Disease and Other Eye DisordersOcugen, Inc.
The Board of Trustees of the University of Illinois
Patented Case2017-03-219597328US20160243116A1
Sandeep Jain
Uday Bhaskar Kompella
Shankar Musunuri
United States
United States
United States
TRUONG, QUANGLONG N
2015-08-2514834951METHOD FOR USE OF A DOUBLE-STRUCTURED TISSUE IMPLANT FOR TREATMENT OF TISSUE DEFECTSHistogenics CorporationPatented Case2018-06-129993326US20150359623A1
Sonya Shortkroff
Laurence J.B. Tarrant
Eric J. Roos
Robert Lane Smith
Hans P.I. Claesson
United States
United States
United States
United States
United States
SCHERBEL, TODD J
2014-12-1914577610CELL-SUPPORT MATRIX HAVING NARROWLY DEFINED UNIFORMLY VERTICALLY AND NON-RANDOMLY ORGANIZED POROSITY AND PORE DENSITY AND A METHOD FOR PREPARATION THEREOFHistogenics CorporationPatented Case2017-07-119701940US20150104872A1
R. Lane Smith
Laurence J.B. Tarrant
Akihiko Kusanagi
Hans P.I. Claesson
United States
United States
United States
United States
KOSAR, AARON J
2014-12-0214558080CELL AND TISSUE CULTURE CONTAINERHistogenics CorporationPatented Case2018-09-1810077420US20160152945A1
Eric Blahut
United States
PRAKASH, GAUTAM
2014-02-0714175499DOUBLE-STRUCTURED TISSUE IMPLANT AND A METHOD FOR PREPARATION AND USE THEREOFHistogenics CorporationPatented Case2016-07-199393347US20140302227A1
Hans Peter Ingemar Claesson
Laurence J.B. Tarrant
Robert Lane Smith
Sonya Shortkroff
United States
United States
United States
United States
RUSSEL, JEFFREY E
2013-05-2013897816METHOD FOR USE OF A DOUBLE-STRUCTURED TISSUE IMPLANT FOR TREATMENT OF TISSUE DEFECTSHistogenics CorporationPatented Case2015-10-069149562US20130259910A1
Sonya Shortkroff
Laurence J. B. Tarrant
Eric J. Roos
Robert Lane Smith
Hans P. I. Claesson
United States
United States
United States
United States
United States
SCHERBEL, TODD J

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
AGENUS INC (AGEN)United States$0.383B1.41
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
Surrozen, Inc./DE (SRZN)United States$0.395B